SCHEMBL6986606

SCHEMBL6986606

CCOC(=O)c1ccc(CCC(CNC(=O)OC(C)(C)C)SC(C(=O)OC)C(=O)OC)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
SYK P43405 1/20 0.35
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986607 1.00 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6996062 1.00 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6993531 0.87 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL7000492 0.87 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6993528 0.87 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL7092530 0.85 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL7092531 0.85 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6989769 0.84 HDAC3 (0.41) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6989772 0.84 HDAC3 (0.41) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6992685 0.84 HDAC3 (0.41) SERPINE1HDAC3HDAC4HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed
EP-0846111-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1998-06-10 EP disclosed
WO-1996040674-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed